Fennec Pharmaceuticals (FENC) Cash & Equivalents Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 38.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.12% |
| Sep 30, 2025 | -45.57% |
| Jun 30, 2025 | -56.55% |
| Mar 31, 2025 | -55.70% |
| Dec 31, 2024 | 100.72% |
| Sep 30, 2024 | 225.19% |
| Jun 30, 2024 | 187.83% |
| Mar 31, 2024 | 285.74% |
| Dec 31, 2023 | -44.19% |
| Sep 30, 2023 | -58.33% |
| Jun 30, 2023 | 0.29% |
| Mar 31, 2023 | -27.33% |
| Dec 31, 2022 | 12.67% |
| Sep 30, 2022 | 22.26% |
| Jun 30, 2022 | -45.35% |
| Mar 31, 2022 | -31.74% |
| Dec 31, 2021 | -30.46% |
| Sep 30, 2021 | -26.63% |
| Jun 30, 2021 | -29.53% |
| Mar 31, 2021 | 170.18% |
| Dec 31, 2020 | 122.30% |
| Sep 30, 2020 | 117.62% |
| Jun 30, 2020 | 183.73% |
| Mar 31, 2020 | -51.06% |
| Dec 31, 2019 | -40.08% |
| Sep 30, 2019 | -37.86% |
| Jun 30, 2019 | -46.76% |
| Mar 31, 2019 | -24.28% |
| Dec 31, 2018 | -19.39% |
| Sep 30, 2018 | 153.14% |
| Jun 30, 2018 | 150.59% |
| Mar 31, 2018 | 721.87% |
| Dec 31, 2017 | 619.82% |
| Sep 30, 2017 | 113.53% |
| Jun 30, 2017 | 101.38% |
| Mar 31, 2017 | 496.51% |
| Dec 31, 2016 | 316.77% |
| Sep 30, 2016 | 232.14% |
| Jun 30, 2016 | 174.06% |
| Mar 31, 2016 | -71.56% |
| Dec 31, 2015 | -59.17% |
| Sep 30, 2015 | 130.35% |
| Jun 30, 2015 | 82.66% |
| Mar 31, 2015 | 43.20% |
| Dec 31, 2014 | 38.73% |
| Sep 30, 2014 | 10.22% |
| Jun 30, 2014 | 0.79% |
| Mar 31, 2014 | -29.43% |
| Dec 31, 2013 | -27.79% |
| Sep 30, 2013 | -81.19% |
| Jun 30, 2013 | -71.92% |
| Mar 31, 2013 | -59.82% |
| Dec 31, 2012 | -56.52% |
| Sep 30, 2012 | -53.68% |
| Jun 30, 2012 | -47.34% |
| Mar 31, 2012 | -6.05% |
| Dec 31, 2011 | -10.93% |
| Sep 30, 2011 | -6.48% |
| Jun 30, 2011 | -4.78% |